Amyris delivers high-performance alternatives to petroleum, plant and animal-based products across a wide range of consumer and industry segments. Our products offer customers a way to reduce environmental impact with No Compromise™ in performance or availability. We are making better chemistry biologically.

Jul 30, 2018

Amyris BIOSSANCE Brand Executes Significant Expansion with Agreement to Launch Across all 668 Sephora Inside JCPenney Stores

EMERYVILLE, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- Biossance™, the high growth clean beauty brand from Amyris, Inc. (NASDAQ:AMRS), today announced that it has executed an agreement with Sephora to launch the brand across all 668 of Sephora’s Inside JCPenney locations beginning in September 2018. Driven by consumer demand for leading clean beauty products, the Biossance brand’s rapid expansion has continued in the U.S., Canada and recently in Brazil, by providing No Compromise Beauty™ non-toxic products that perform. This increases the store count where you can find Biossance from 140 locations to over 800 locations in the Americas.

This expansion in the number of retail locations supporting clean beauty and making Biossance available to consumers is a critical component of delivering over 300% sales growth for Biossance that Amyris expects for 2018.

“We continue to be encouraged by the momentum in our clean beauty business,” said Caroline Hadfield, President of Biossance. “Consumers across a variety of geographies continue to embrace Biossance’s Clean Beauty Commitment, which calls for only using a few simple and safe ingredients in products that achieve “best in class” results and come in sustainable packaging. This is fostering broader market penetration and solid business performance for Biossance.”

Biossance was founded in 2015 by Amyris, a biotechnology company originally funded by the Bill & Melinda Gates Foundation. As the first fully Environmental Working Group (EWG) VERIFIED™ brand in Sephora, Biossance blacklists over 2,000 potentially harmful and toxic ingredients and uses tree-free, responsible outer packaging. Biossance has become a top-seller at Sephora stores in the U.S., with immediate traction in sales shortly after the brand’s debut in the Canada and Brazil markets.

For more information on Biossance, please visit Biossance.com. Join the conversation on Instagram at @biossance using the hashtag #biossance.

About Biossance
Pioneering sustainable beauty through biotechnology, at Biossance we created a 100% plant-based squalane skincare line that is delivering the leading skin moisturizer while using only safe and sustainable ingredients. We formulate with a No Compromise™ approach, proudly blacklisting over 2,000 potentially harmful ingredients because the products you use make a difference for your health and the health of the planet. Biossance makes sure only the most trustworthy and powerful ingredients make the final cut. Because we believe and are committed to delivering both best performing and clean beauty products. The full Biossance skin care line can be found at www.Biossance.com and www.SEPHORA.com.

About Amyris
Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise™ products and services across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com.

Forward-Looking Statements

This release contains forward-looking statements, and any statements other than statements of historical fact could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as the anticipated launch of Biossance in Sephora’s Inside JCPenney locations, including the number of locations and the timing thereof, expected Biossance sales growth for 2018, and anticipated Biossance market penetration and business performance), that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including risks related to Amyris's liquidity and ability to fund operating and capital expenses, potential delays or failures in development, production and commercialization of products, risks related to Amyris's reliance on third parties, and other risks detailed from time to time in filings Amyris makes with the Securities and Exchange Commission, including Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Amyris disclaims any obligation to update information contained in these forward-looking statements, whether as a result of new information, future events, or otherwise.

Amyris, the Amyris logo, No Compromise, and Biossance are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries. All other trademarks are the property of their respective owners.

Contacts:

Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris, Inc.
+1 (510) 740-7481
investor@amyris.com
pr@amyris.com

Stephanie Halperin
BOLD PR
stephanie@boldpr.com
+1 (646) 214-5727 x103